Claritin-d and Swallowing difficulty - a phase IV clinical study of FDA data

Summary:

Swallowing difficulty is reported as a side effect among people who take Claritin-d (loratadine; pseudoephedrine sulfate), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Claritin, and have Depression.

The phase IV clinical study analyzes which people have Swallowing difficulty when taking Claritin-d. It is created by eHealthMe based on reports of 6,243 people who have side effects when taking Claritin-d from the FDA, and is updated regularly.

What is Claritin-d?

Claritin-d has active ingredients of loratadine; pseudoephedrine sulfate. It is often used in allergies. eHealthMe is studying from 7,055 Claritin-d users. Check the latest studies of Claritin-d.

What is Swallowing difficulty?

Swallowing difficulty is found to be associated with 2,406 drugs and 3,350 conditions by eHealthMe. Check the latest studies of Swallowing difficulty.

On Jun, 15, 2026

6,243 people reported to have side effects when taking Claritin-d.
Among them, 71 people (1.14%) have Swallowing difficulty.

Could Claritin-d cause Swallowing difficulty?

Among these 71 people:

How long have people been on Claritin-d when they have Swallowing difficulty? *

What is the gender of people who have Swallowing difficulty when taking Claritin-d? *

female: 64.18 %
male: 35.82 %

What is the age of people who have Swallowing difficulty when taking Claritin-d? *

What are other drugs people take besides Claritin-d? *

What are other side effects people have besides Swallowing difficulty? *

Foreign Body Trauma (injury by foreign particle): 16 people, 22.54%
Oesophageal Obstruction (blockage of oesophagus): 10 people, 14.08%
Chest Pain: 9 people, 12.68%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 8 people, 11.27%
Nausea (feeling of having an urge to vomit): 8 people, 11.27%
Oesophagitis (inflammation of oesophagus): 7 people, 9.86%
Oesophageal Stenosis (narrowing of oesophagus): 6 people, 8.45%
Indigestion: 6 people, 8.45%
Dyspnea (difficult or laboured breathing): 6 people, 8.45%
Retching (strong involuntary effort to vomit): 5 people, 7.04%

What are the existing conditions these people have? *

Depression: 3 people, 4.23%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 2.82%
Sinus Congestion (blockage of sinus): 2 people, 2.82%
Seasonal Allergy (allergic condition due to certain season): 2 people, 2.82%
Weight Loss: 1 person, 1.41%
Increased Upper Airway Secretion: 1 person, 1.41%
Asthma: 1 person, 1.41%
Breast Cancer: 1 person, 1.41%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 1 person, 1.41%
Gastric Ulcer (stomach ulcer): 1 person, 1.41%

* Approximation only. Some reports may have incomplete information.

Do you take Claritin-d and have Swallowing difficulty?

- Check whether Swallowing difficulty is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Claritin-d:

Claritin-d (7,055 reports)

Swallowing difficulty treatments and more:

Swallowing difficulty (112,312 reports)

How severe was Swallowing difficulty and when was it recovered:

Swallowing difficulty in Claritin-d

Expand to all the drugs that have ingredients of loratadine; pseudoephedrine sulfate:

Swallowing difficulty and drugs with ingredients of loratadine; pseudoephedrine sulfate (76 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Claritin-d:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swallowing difficulty:

Swallowing difficulty (2,406 drugs)

Browse all the conditions that are associated with Swallowing difficulty:

Swallowing difficulty (3,350 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on loratadine; pseudoephedrine sulfate (the active ingredients of Claritin-d) and Claritin-d (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.